Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Susan Julius

Addiction Medicine Baton Rouge, LA Medical Doctor

NPI 1407921935 CMS profile 1058106

2414 Bunker Hill Dr, Baton Rouge, LA 70808

Open in the dashboard

General payments

$255,020

540 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Susan Julius of Baton Rouge, LA is reported in the CMS Open Payments database as having received $255,020 across 540 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Addiction Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $76,052 120
2024 General $98,742 133
2023 General $45,339 107
2022 General $32,869 85
2021 General $776 34
2020 General $638 33
2019 General $605 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Susan Julius
  • Addiction Medicine median
  • Middle half of Addiction Medicine
  • National median

In program year 2025, general payments to Susan Julius were reported at $76,052. Among 306 Addiction Medicine profiles paid that year, the median was $147 and the middle half received between $46 and $381.

Show as a table
Year Susan Julius Addiction Medicine median Middle half National median
2019 $605 $96 $32–$265 $163
2020 $638 $53 $20–$176 $114
2021 $776 $86 $24–$265 $132
2022 $32,869 $89 $27–$330 $149
2023 $45,339 $102 $39–$363 $160
2024 $98,742 $110 $38–$311 $164
2025 $76,052 $147 $46–$381 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Gilead Sciences, Inc. $241,874 312 payments
  2. Eli Lilly and Company $6,402 10 payments
  3. Vanda Pharmaceuticals Inc. $1,961 67 payments
  4. AbbVie, Inc. $894 30 payments
  5. Axsome Therapeutics, Inc. $711 13 payments
  6. ITI, Inc. $675 18 payments
  7. Braeburn Inc. $535 13 payments
  8. Alkermes, Inc. $486 18 payments
  9. Indivior Inc. $387 14 payments
  10. Otsuka America Pharmaceutical, Inc. $326 9 payments
  11. Other $770 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $164,046 58 payments
  2. Travel and Lodging $57,059 91 payments
  3. Consulting Fee $19,975 6 payments
  4. Food and Beverage $13,827 378 payments
  5. Education $113 7 payments
Products named General payments · program years 2019–2025
  1. Epclusa $221,789 228 payments
  2. HETLIOZ $1,456 56 payments
  3. VRAYLAR $769 24 payments
  4. Auvelity $711 13 payments
  5. FANAPT $660 16 payments
  6. BRIXADI $535 13 payments
  7. VIVITROL $462 17 payments
  8. CAPLYTA Psychiatry $447 10 payments
  9. SUBLOCADE $312 11 payments
  10. CAPLYTA Psychiatry $228 8 payments
  11. Other $1,603 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

540 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Addiction Medicine in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record